Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma
|
168 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.941 | 34 | 2005 | 2020 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 1.000 | 58 | 2005 | 2020 | ||||||
Adenocarcinoma of lung stage IIIB
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Adenocarcinoma of lung, stage IV
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2013 | 2019 | ||||||
Adenocarcinoma of small intestine
|
5 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Adenocarcinoma, metastatic
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Adenocarcinoma, Tubular
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2007 | 2018 | ||||||
Adult Penile Carcinoma
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Advanced lung cancer
|
9 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Androgen-Insensitivity Syndrome
|
176 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Breast Carcinoma
|
2793 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||||
Bronchioloalveolar Adenocarcinoma
|
5 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Carcinogenesis
|
355 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 0.667 | 3 | 2012 | 2016 | ||||||
Carcinoma
|
103 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
Carcinoma breast stage IV
|
14 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Carcinoma of lung
|
1204 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.968 | 31 | 2006 | 2019 | ||||||
Carcinoma, Large Cell
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
CNS metastases
|
14 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Diarrhea
|
63 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Exanthema
|
14 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
HER2 gene amplification
|
14 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Hyperplastic Polyp
|
22 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
Laryngeal Squamous Cell Carcinoma
|
30 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Li-Fraumeni Syndrome
|
206 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2014 | 2014 |